Viewing nowCombinationLexpazique Tablet 5/160 mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 201308506 · Approved 2013.07.30 · Insurance code 661904210
Improvement of blood pressure control in essential hypertension
In patients with essential hypertension, when blood pressure is not adequately controlled with monotherapy of amlodipine or valsartan, combining these two medications can lower blood pressure more effectively. Amlodipine dilates blood vessels to lower blood pressure, while valsartan blocks the action of hormones involved in raising blood pressure. This combination therapy helps improve blood pressure control and reduces the risk of cardiovascular diseases. Therefore, a combination of amlodipine and valsartan is used in the treatment of essential hypertension.
The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). If blood pressure is not controlled with monotherapy of amlodipine or valsartan, administration is as follows: ㆍ 5/80 mg: used in patients whose blood pressure is not adequately controlled with monotherapy of amlodipine 5 mg or valsartan 80 mg.
The safety and efficacy in pediatric patients under 18 years have not been established, so the administration of this medication is not recommended.
This medication can cause serious injury or death to the fetus or newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients with allergies to this drug or similar drugs, women who are pregnant or breastfeeding, patients with severe kidney or liver dysfunction, and patients with certain heart diseases should not take this medication. Patients with low sodium or fluid levels in the body may experience hypotension, so their condition should be checked before administration, and blood pressure should be closely monitored during administration. Patients with high potassium levels in the blood or those taking potassium supplements should have their potassium levels frequently checked, and patients with impaired kidney function should also be monitored carefully. This medication requires kidney function evaluation and blood pressure monitoring in patients after heart failure or myocardial infarction, and it should be used cautiously in certain heart disease patients. Dizziness, drowsiness, headaches, and other symptoms may occur during the use of this medication, so caution is advised when driving or operating machinery. This drug may interact with other medications, so especially when taken with blood pressure medications, potassium-raising drugs, anti-inflammatory drugs, and certain antibiotics, consult with a physician or pharmacist. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid it. The safety and effectiveness in pediatric patients under 18 years have not been established, so this medication is not recommended for use in this age group. In case of overdose, severe hypotension or heart problems may occur, so strict adherence to the prescribed dosage is necessary, and medical attention should be sought immediately in case of overdose.
Urticaria, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in oral or ocular mucous membranes, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities with cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage can maintain the drug's efficacy longer.
Dark yellow oblong film-coated tablet
28 tablets (14 tablets/AluAlu×2), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.